The concept of IgM autoantibodies as pathogenic and causative drivers of autoimmune diseases is further supported by a recent study reporting on therapeutic plasma exchange in patients suffering from autoimmune neuropathy [74]. This evidence concerns the gene CD40LG and autoimmune neuropathy.